Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
BMJ (Clinical Research Ed.)|July 8, 2026
Advances in systemic therapies for advanced prostate cancerDaniel S Childs, Andrew W Hahn, Praful Ravi, et al.
Urologic Oncology|September 12, 2017
PD-1 checkpoint inhibition: Toxicities and managementAndrew W Hahn, David M Gill, Neeraj Agarwal, et al.
Journal of Neuro-Oncology|April 29, 2006
Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastomaSusan E Spiller, Ali C Ravanpay, Andrew W Hahn, et al.
Molecular and Clinical Oncology|January 27, 2017
Complete response to azacitidine priming and nab-paclitaxel in non-Hodgkin lymphoma resistant to biochemotherapyRandy C Bowen, Andrew W Hahn, Thomas W Butler, et al.
Current Treatment Options in Oncology|February 12, 2019
Management of Nonmetastatic Castration-Resistant Prostate Cancer: Recent Advances and Future DirectionJohn Esther, Benjamin L Maughan, Neysi Anderson, et al.
Current Treatment Options in Oncology|April 29, 2025
Advances in Targeted Therapy for Metastatic Prostate CancerKabir Grewal, Tanya B Dorff, Sagar S Mukhida, et al.
World Journal of Oncology|September 18, 2018
DNA Damage Repair (DDR) Mutations and the Utility of High-Risk Genetics Clinics in Metastatic Castration-Refractory Prostate Cancer (mCRPC)Nityam Rathi, Neysi Anderson, Samantha Greenberg, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Metastatic Castration-Sensitive Prostate Cancer: Optimizing Patient Selection and TreatmentAndrew W Hahn, Celestia S Higano, Mary-Ellen Taplin, et al.
Pageof 11